Last deal

$6.21M
Local Amount - CAD 8.45M

Amount

Post-IPO Equity

Stage

16.10.2023

Date

3

all rounds

$24.36M

Total amount

date founded

Financing round

General

About Company
Neurodyn develops bioactives for neuroprotection and licenses to pharmaceutical companies.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Neurodyn Cognition

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company identifies bioactive compounds in natural treatments, validates therapeutic candidates for diseases such as Parkinson's and Alzheimer's, and explores faster alternatives to traditional drug development. Neurodyn's expertise comes from international partners, in-house medicinal chemistry capability, and proprietary animal models of neurological disease.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Alzprotect

Alzprotect

AlzProtect is a biopharmaceutical company developing new bioactive molecules for neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Street, MD 21154, USA

total rounds

5

total raised

$15.87M
Cyxone

Cyxone

Cyxone is a biotech company that develops drugs to improve the quality of life for people with severe autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Malmö, Sweden
ENTEROME

ENTEROME

Enterome develops targeted therapeutics based on its unique knowledge of the gut microbiome and its interactions with the human body.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Paris, France

total rounds

9

total raised

$130.58M
FundaMental Pharma

FundaMental Pharma

FanaMental Pharma is developing neuroprotective small molecules for the treatment of currently untreatable human neurological conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Heidelberg, Germany

total rounds

2

total raised

$9.02M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$24.36M

Money Raised

Their latest funding was raised on 16.10.2023. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.10.2023
$6.21M
Local Amount - CAD 8.45M
30.05.2023
$6.5M
08.02.2023
$5.06M
Local Amount - CAD 6.8M
Co-Investors

People

Founders
2
Jayant Panchal
Jayant Panchal

Jayant Panchal

Jay Panchal is the CEO and Co-Founder at Alpha Cognition. Before that, he was the CEO and Co-Founder of Goodybag, Inc (Sold to Bite Squad in 2016).

current job

Alpha Cognition
Alpha Cognition

organization founded

2

Jayant Panchal

Denis Kay
Denis Kay

Denis Kay

current job

Alpha Cognition
Alpha Cognition

organization founded

2

Denis Kay

Employee Profiles
3

Cedric O’Gorman

Chief Medical Officer

Jayant Panchal

Jayant Panchal

CEO & Co-Founder

Denis Kay

Denis Kay

Co-Founder & Chief Scientific Officer

Activity

Recent News
4
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week